BRPI0919551A2 - agente e método de formação de imagem in vivo, composto precursor, kit, cassete, composição radiofarmacêutica, e, métodos para a preparação do agente de formação de imagem in vivo, e para diagnóstico de uma condição - Google Patents

agente e método de formação de imagem in vivo, composto precursor, kit, cassete, composição radiofarmacêutica, e, métodos para a preparação do agente de formação de imagem in vivo, e para diagnóstico de uma condição

Info

Publication number
BRPI0919551A2
BRPI0919551A2 BRPI0919551A BRPI0919551A BRPI0919551A2 BR PI0919551 A2 BRPI0919551 A2 BR PI0919551A2 BR PI0919551 A BRPI0919551 A BR PI0919551A BR PI0919551 A BRPI0919551 A BR PI0919551A BR PI0919551 A2 BRPI0919551 A2 BR PI0919551A2
Authority
BR
Brazil
Prior art keywords
imaging agent
vivo imaging
diagnosing
cassette
kit
Prior art date
Application number
BRPI0919551A
Other languages
English (en)
Portuguese (pt)
Inventor
Shan Bo
O' Shea Dennis
John Wadsworth Harry
Marie Passmore Joanna
John Trigg William
Original Assignee
Ge Healthcare Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ge Healthcare Ltd filed Critical Ge Healthcare Ltd
Publication of BRPI0919551A2 publication Critical patent/BRPI0919551A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/041—Heterocyclic compounds
    • A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K51/0446—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
BRPI0919551A 2008-10-02 2009-10-02 agente e método de formação de imagem in vivo, composto precursor, kit, cassete, composição radiofarmacêutica, e, métodos para a preparação do agente de formação de imagem in vivo, e para diagnóstico de uma condição BRPI0919551A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10203108P 2008-10-02 2008-10-02
GBGB0818738.7A GB0818738D0 (en) 2008-10-13 2008-10-13 Imaging neuroflammation
PCT/EP2009/062827 WO2010037851A2 (en) 2008-10-02 2009-10-02 Imaging neuroinflammation

Publications (1)

Publication Number Publication Date
BRPI0919551A2 true BRPI0919551A2 (pt) 2019-09-24

Family

ID=40083940

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0919551A BRPI0919551A2 (pt) 2008-10-02 2009-10-02 agente e método de formação de imagem in vivo, composto precursor, kit, cassete, composição radiofarmacêutica, e, métodos para a preparação do agente de formação de imagem in vivo, e para diagnóstico de uma condição

Country Status (12)

Country Link
US (1) US9481685B2 (enExample)
EP (1) EP2346880A2 (enExample)
JP (1) JP5730206B2 (enExample)
KR (1) KR20110071072A (enExample)
CN (1) CN102171218B (enExample)
AU (1) AU2009299807B2 (enExample)
BR (1) BRPI0919551A2 (enExample)
CA (1) CA2739207A1 (enExample)
GB (1) GB0818738D0 (enExample)
MX (1) MX2011003532A (enExample)
RU (1) RU2512288C2 (enExample)
WO (1) WO2010037851A2 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201016038D0 (en) * 2010-09-24 2010-11-10 Ge Healthcare Ltd In vivo imaging method
GB201016411D0 (en) * 2010-09-30 2010-11-10 Ge Healthcare Ltd In vivo imaging method for cancer
KR101602912B1 (ko) 2013-09-13 2016-03-11 주식회사 바이오이미징코리아 [18ｆ]플루오르메틸기가 도입된 뇌신경염증 표적 양성자방출단층촬영 방사성추적자, 이의 합성 및 그를 이용한 생물학적 결과 평가 방법
GB201316764D0 (en) * 2013-09-20 2013-11-06 Ge Healthcare Ltd Novel compounds
GB201316766D0 (en) * 2013-09-20 2013-11-06 Ge Healthcare Uk Ltd Macrophage Imaging
KR101720288B1 (ko) 2016-05-11 2017-03-28 (주)바이오액츠 뇌 영상용 염료 및 이의 제조방법
CN110922412A (zh) * 2018-09-20 2020-03-27 复旦大学 具有抗精神病作用药物化合物的不对称合成方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07165721A (ja) 1993-12-15 1995-06-27 Sumitomo Chem Co Ltd 放射性イソキノリンカルボキサミド誘導体
CA2313054A1 (en) * 1997-12-03 1999-06-10 Taisho Pharmaceutical Co., Ltd. Nitrogen-containing tetracyclic compounds
AUPP278498A0 (en) * 1998-04-03 1998-04-30 Australian Nuclear Science & Technology Organisation Peripheral benzodiazepine receptor binding agents
FR2788696B1 (fr) * 1999-01-26 2004-03-05 Synthelabo Utilisation de derives de pyridazino [4,5-b] indole-1-acetamide pour la preparation de medicaments destines aux maladies du systeme nerveux central
FR2788776B1 (fr) * 1999-01-26 2001-02-23 Synthelabo Derives de 4-oxo-3, 5-dihydro-4h-pyridazino [4,5-b] indole-1 -carboxamide, leur preparation et leur application en therapeutique
US6870069B2 (en) * 2003-01-10 2005-03-22 National Institute Of Radiological Sciences Phenyloxyaniline derivatives
JP2004231647A (ja) * 2003-01-10 2004-08-19 Natl Inst Of Radiological Sciences フェニルオキシアニリン誘導体
GB0327494D0 (en) * 2003-11-26 2003-12-31 Amersham Plc Novel imaging agents
GB0523506D0 (en) * 2005-11-18 2005-12-28 Hammersmith Imanet Ltd Novel in vivo imaging compounds

Also Published As

Publication number Publication date
KR20110071072A (ko) 2011-06-28
CA2739207A1 (en) 2010-04-08
JP2012504581A (ja) 2012-02-23
WO2010037851A2 (en) 2010-04-08
CN102171218A (zh) 2011-08-31
AU2009299807B2 (en) 2014-10-02
CN102171218B (zh) 2015-05-13
GB0818738D0 (en) 2008-11-19
WO2010037851A3 (en) 2010-07-01
AU2009299807A1 (en) 2010-04-08
EP2346880A2 (en) 2011-07-27
JP5730206B2 (ja) 2015-06-03
MX2011003532A (es) 2011-06-09
US9481685B2 (en) 2016-11-01
US20110190618A1 (en) 2011-08-04
RU2512288C2 (ru) 2014-04-10
RU2011111787A (ru) 2012-11-20

Similar Documents

Publication Publication Date Title
BRPI1010261A2 (pt) agente e método de formação de imagem in vivo, composto precursos, métodos para a preparação de um composto precursor e do agente de formação de imagem in vivo, e para diagnostico de uma condição, kit, cassete,e , composição radiofarmaceutica.
BRPI0919551A2 (pt) agente e método de formação de imagem in vivo, composto precursor, kit, cassete, composição radiofarmacêutica, e, métodos para a preparação do agente de formação de imagem in vivo, e para diagnóstico de uma condição
ZA201004112B (en) Non-destructive testing,in particular for tubes during manufacture or in the finished state
BRPI0814811A2 (pt) Composto, agente, método, e composição de diagnóstico, uso de um composto, e, método de formação de imagem
IL211527A0 (en) Compounds and methods for 18f labeled agents, compositions comprising such compounds and their use for diagnostic imaging
ZA200803997B (en) Diagnostic kits and methods for oesophageal abnormalities
GB0716885D0 (en) Diagnostic agent
EP2192134A4 (en) PHOTOSENSITIVE COMPOSITION, PATTERN FORMATION METHOD EMPLOYING THE PHOTOSENSITIVE COMPOSITION, AND COMPOUND USED IN THE PHOTOSENSITIVE COMPOSITION
IL195271A0 (en) Composition for diagnosing amyloid-related disease
ZA201000983B (en) Methods and compositions for diagnosing disease
EP2129284A4 (en) IMAGING AND TOOLS FOR USE WITH MOBILE ORGANS
FI20070768A0 (fi) Röntgentietokonetomografialaitteisto
PL2530093T3 (pl) Związek indocyjaninowy, jego metoda syntezy, metoda jego oczyszczania, kompozycja diagnostyczna wykorzystująca związek indocyjaninowy oraz urządzenie do pomiaru biokinetyki in vivo i urządzenie do wizualizacji krążenia wykorzystujące kompozycję diagnostyczną
EP2051107A4 (en) POSITRON-COMPUTERIZED TOMOGRAPHY APPARATUS
ZA200900199B (en) Hard alloys with dry composition
BR112013013285A2 (pt) agente de formação de imagem, precursor, métodos de preparação do agente de formação de imagem, e de formação de imagem, composição radiofarmacêutica, kit para a preparação da composição radiofarmacêutica, e, uso do agente de formação de imagem
EP2138168A4 (en) ORAL ADMINISTRATION AGENT AND METHOD FOR PRODUCING THE SAME
EP2253748A4 (en) MONOFILAMENT FOR X-RAY CONTRAST RADIOGRAPHY
EP2023629A4 (en) Storage device, recording method, recording program, imaging device, imaging method, and imaging program
BRPI0817999A2 (pt) Composição oral compreendendo um agente de resfriamento
PT2063916E (pt) Agente de contraste radiográfico para a angiografia experimental e post mortem
WO2007148083A3 (en) Stabilisation of radiopharmaceutical precursors
IL218456A (en) Diagnostic Composition Containing Bite History (2,4,6 - Triodophenyl) and Methods for Diagnosis and Imaging
EP2326952A4 (en) BIOMARKERS, KITS AND METHODS FOR DIAGNOSING, MONITORING AND / OR STADIFYING ALZHEIMER'S DISEASE
WO2008026051A3 (en) 68ga-labelling of a free and macromolecule conjugated macrocyclic chelator at ambient temperature

Legal Events

Date Code Title Description
B08F Application fees: application dismissed [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2543 DE 01-10-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.